Better Health,
Brighter Future
Newsroom
Careers
Contact Us
HCPs
English
français
Canada
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Corporate Philosophy
About Takeda Canada
Message from the GM
Contact Us
Our Partnerships
Compliance
Takeda Worldwide
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Conditions We Treat
ADHD
Chronic Kidney Disease
Crohn's Disease
Gastro esophageal reflux disease (GERD, heartburn)
Gaucher Disease
Gout
Hereditary Angioedema
Hunter Syndrome
Lung Cancer
Multiple Myeloma
Short Bowel Syndrome
Type 2 Diabetes
Ulcerative Colitis
Our Medicines
Medications Return Program
Helping Canadian Patients
Our Pipeline of New Treatments
OnePath Patient Support Program
Vyvanse Assistance Program
How Takeda Canada does Business
Canadian R&D Initiatives
Our Stories
Our Stories
Find out Takeda's stories related on Innovation, Caring and Heritage
Learn more
Innovation
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
IBD Patient Story
Multiple Myeloma Patient Story
#InTheirShoes
Rare Diseases Patient Story
Heritage
Takeda Canada's History
Keys to Aging Gracefully
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
Learn more
Our Commitment
Giving Back to the Community
Product Donations
Grants, Donations and Sponsorships
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
Takeda Canada Recognized as Top Employer
Shire Acquisition is Completed
News Releases
News Releases
Enter
Year of release
2020
2019
2018
2017
2016
2015
2014
July, 2020
July 7, 2020
2020-07-07
OnePath
July 2, 2020
2020-07-02
July 1 LEO
May, 2020
May 11, 2020
2020-05-11
COVID HCP Letter
April, 2020
April 9, 2020
2020-04-09
ENTYVIO SC NoC
March, 2020
March 16, 2020
2020-03-16
COVID19 HCP Letter
February, 2020
February 4, 2020
2020-02-04
Princess Margaret Research Announcement
January, 2020
January 24, 2020
2020-01-24
ON Patients Gain Better Access to INTUNIV XR
November, 2019
November 22, 2019
2019-11-22
TAKHZYRO receives positive CADTH recommendation
1
2
3
4
5
TOP
